Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R. Cheli Y, et al. Among authors: passeron t. Mol Cancer. 2021 Jan 27;20(1):21. doi: 10.1186/s12943-021-01319-5. Mol Cancer. 2021. PMID: 33504341 Free PMC article. No abstract available.
Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
Montaudié H, Albert-Sabonnadière C, Acquacalda E, Fontas E, Danré A, Roux C, Ortonne JP, Lacour JP, Euller-Ziegler L, Passeron T. Montaudié H, et al. Among authors: passeron t. J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1186-91. doi: 10.1111/jdv.12255. Epub 2013 Aug 24. J Eur Acad Dermatol Venereol. 2014. PMID: 23981008
PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2.
Pierron A, Le Pape E, Montaudié H, Castela E, De Donatis GM, Allegra M, Bertolotto C, Rocchi S, Cheli Y, Ballotti R, Passeron T. Pierron A, et al. Among authors: passeron t. J Dermatol Sci. 2014 Mar;73(3):258-61. doi: 10.1016/j.jdermsci.2013.11.003. Epub 2013 Nov 11. J Dermatol Sci. 2014. PMID: 24289988 No abstract available.
Inhibition of melanogenesis by the antidiabetic metformin.
Lehraiki A, Abbe P, Cerezo M, Rouaud F, Regazzetti C, Chignon-Sicard B, Passeron T, Bertolotto C, Ballotti R, Rocchi S. Lehraiki A, et al. Among authors: passeron t. J Invest Dermatol. 2014 Oct;134(10):2589-2597. doi: 10.1038/jid.2014.202. Epub 2014 Apr 22. J Invest Dermatol. 2014. PMID: 24756109 Free article.
Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial.
Boukari F, Jourdan E, Fontas E, Montaudié H, Castela E, Lacour JP, Passeron T. Boukari F, et al. Among authors: passeron t. J Am Acad Dermatol. 2015 Jan;72(1):189-90.e1. doi: 10.1016/j.jaad.2014.08.023. Epub 2014 Oct 22. J Am Acad Dermatol. 2015. PMID: 25443629 Clinical Trial. No abstract available.
372 results